roche: Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19, Health News, ET HealthWorld

2022-06-25 03:24:02 By : Mr. Oscar Liao

We have updated our terms and conditions and privacy policy Click "Continue" to accept and continue with ET HealthWorld

Dear user, ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website. You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website. If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET HealthWorld.

Govt panel recommends emergency approval for SII's Covovax for 7-11 year olds2 hrs ago

Gavi renews focus on integration of COVAX into other core routine immunisation services14 hrs ago

The unsung hero in faster holistic recovery

Technological Disruption in Indian Health & Pharma

Do you think you are up for the challenge?

Holistic Solutions For A Healthier India

The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of COVID-19. Potential benefits of the cobas SARS-CoV-2 Duo test aim to help the healthcare community with contact tracing, patient triage and the approach to medical care.

125000+ Industry Leaders read it everyday

After getting inputs about an exchange of bribe, the CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, L Praveen Kumar, Associate Vice President and Head-National Regulatory Affairs (NRA), Biocon Biologics Limited, Bangalore; and Dinesh Dua, Director at Synergy Network India Private Limited, among others.

The Tamil Nadu Medical Services Corporation has blacklisted Abbott Healthcare for five years for hiding the fact that it has been banned by Directorate General of Health Services and Employees' State Insurance Corporation.

We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.

Please contact us to know more details.

Get ETHealthworld 's top stories every morning in your email inbox.

125000+ Industry Leaders read it everyday

Follow @ETHealthworld for the latest news, insider access to events and more.